https://ceretype.com/article/calyx-delivers-imaging-biomarkers-to-advance-neuropsychiatric-treatment-developmen/ 2023-04-14T21:53:46+00:00 https://ceretype.com/wp-content/uploads/2023/03/Calyx_Logo-2.png https://ceretype.com/article/ceretype-neuromedicine-closes-second-round-of-seed-financing-to-accelerate-growth/ 2024-01-04T16:08:02+00:00 https://ceretype.com/wp-content/uploads/2024/01/Background-Texture-1_thin-1.png https://ceretype.com/article/ceretype-neuromedicine-unveils-groundbreaking-methods-to-quantify-and-standardize-measures-of-brain-activity-at-the-20th-annual-meeting-of-isctm/ 2024-03-04T17:06:03+00:00 https://ceretype.com/wp-content/uploads/2024/01/Background-Texture-1_thin-1.png https://ceretype.com/article/ceretype-presents-reference-ranges-of-healthy-brain-network-activity-to-inform-cns-treatment-development-at-fall-2024-meeting-of-isctm/ 2026-08-13T18:11:38+00:00 https://ceretype.com/wp-content/uploads/2024/01/Background-Texture-1_thin-1.png https://ceretype.com/article/american-diabetes-association-2026-ceretype-leads-fmri-component-of-novo-nordisk-cagrisema-trial/ 2026-08-13T18:23:08+00:00 https://ceretype.com/wp-content/uploads/2023/03/Cloud@2x.png https://ceretype.com/wp-content/uploads/2026/08/ADA-abstract-title-scaled.png https://ceretype.com/article/american-diabetes-association-2026-ceretype-leads-fmri-component-of-novo-nordisk-cagrisema-trial-2/ 2026-10-20T16:58:28+00:00 https://ceretype.com/wp-content/uploads/2023/03/Cloud@2x.png https://ceretype.com/wp-content/uploads/2026/10/Screenshot-2026-10-20-123939.png